Abstract:Abstract Background From January 2020 to December 2022, China implemented “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” to block the COVID-19 epidemic; however, the immediate and long-term impact of three strategies on other infectious diseases and the difference in their impact is currently unknown. We aim to provide a more comprehensive understanding of the impact of non-pharmacological interventions (NPIs) on infectious diseases in China. Methods We collected data on the monthly case count of infectious diseases in China from January 2015 to July 2022. After considering long-term trends using the Cox-Stuart test, we performed the two ratio Z tests to preliminary analyze the impact of three strategies on infectious diseases. Next, we used a multistage interrupted-time-series analysis fitted by the Poisson regression to evaluate and compare the immediate and long-term impact of three strategies on infectious diseases in China. Results Compared to before COVID-19, the incidence of almost all infectious diseases decreased immediately at stages 1, 2, and 3; meanwhile, the slope in the incidence of many infectious diseases also decreased at the three stages. However, the slope in the incidence of all sexually transmitted diseases increased at stage 1, the slope in the incidence of all gastrointestinal infectious diseases increased at stage 2, and the slope in the incidence of some diseases such as pertussis, influenza, and brucellosis increased at stage 3. The immediate and long-term limiting effects of “Normalized-control” on respiratory-transmitted diseases were weaker than “First-level-response” and the long-term limiting effects of “Dynamic-COVID-zero” on pertussis, influenza, and hydatid disease were weaker than “Normalized-control”. Conclusions Three COVID-19 control strategies in China have immediate and long-term limiting effects on many infectious diseases, but there are differences in their limiting effects. Evidence from this study shows that pertussis, influenza, brucellosis, and hydatid disease began to recover at stage 3, and relaxation of NPIs may lead to the resurgence of respiratory-transmitted diseases and vector-borne diseases.

[The dynamic COVID-zero strategy on prevention and control of COVID-19 in China].

[Experience and thinking on the normalization stage of prevention and control of COVID-19 in China].

[To take the initiative in the prevention and control of the coronavirus disease 2019 epidemic in the changing and unchanged strategies]

Analysis on Action Tracking Reports of COVID-19 Informs Control Strategies and Vaccine Delivery in Post-Pandemic Era

The Dynamic COVID-Zero Strategy in China

Dynamic Public Health Interventions Consistent With the Development of COVID-19 Epidemic: The Targeted Prevention and Control Guidelines in Mainland, China

Impact of the COVID-19 pandemic and the dynamic COVID-zero strategy on HIV incidence and mortality in China

Dynamic Zero-Covid strategy curtails mutagenesis and emergence of new variants of the SARS-CoV-2

Public Health Measures and the Control of COVID-19 in China

Modelling the Transmission and Control of COVID-19 in Yangzhou City with the Implementation of Zero-COVID Policy

The COVID-19 pandemic in China: from dynamic zero-COVID to current policy

TRANSMISSION DYNAMICS AND CONTROL STRATEGIES OF COVID-19 IN WUHAN, CHINA

Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China’s Prevention and Control Strategy for the COVID-19 Epidemic

China's "dynamic clearing" epidemic prevention policy: Achievements, challenges, and prospects

Scientific and targeted prevention and control measures to optimize COVID‐19 response

Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis

Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments

Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis

Reflections on the dynamic zero-COVID policy in China

Epidemiological characteristics of seasonal influenza under implementation of Zero-COVID-19 strategy in China

China's COVID-19 Control Strategy and Its Impact on the Global Pandemic